Relief Therapeutics Holding AG (RLF) — Capital Reinvestment Ratio
Relief Therapeutics Holding AG (RLF) has a Capital Reinvestment Ratio of 0.04x as of December 2024, meaning it reinvests 0% of its operating cash flow (CHF359.00K) in capital expenditures (CHF14.00K). Check RLF intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Relief Therapeutics Holding AG Capital Reinvestment Ratio (2006–2006)
This chart tracks Relief Therapeutics Holding AG's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Relief Therapeutics Holding AG generate cash.
Annual Capital Reinvestment Ratio for Relief Therapeutics Holding AG (2006–2006)
Year-by-year Capital Reinvestment Ratio for Relief Therapeutics Holding AG from 2006 to 2006. See Relief Therapeutics Holding AG (RLF) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2006 | 0.21x | CHF2.28 Million | CHF474.60K | — |